The Dangerous Expansion of Adult Vaccinations
Conclusion The vaccination comprises a misguided and unsafe national health care program which claims to prevent disease. Many significant health injuries are associated with vaccinating adults. Government resources are being spent researching and developing new and different vaccinations. Subjecting adults to more vaccinations is likely to cause more health injury and illness. References: http://www.vaccinationcouncil.org/2012/07/05/herd-immunity… http://www.cdc.gov/chronicdisease/overview/ http://www.vaccinationcouncil.org/2011/02/18/60-lab-studies… http://www.cdc.gov/vaccines/schedules/hcp/adult.html http://www.cdc.gov/vaccines/schedules/downloads/adult…pdf http://www.hhs.gov/nvpo/national-adult-immunization-plan… http://www.immunizeforgood.com/vaccines/new-vaccines-on-the-horizon https://www.epa.gov/mercury/health-effects-exposures-mercury http://articles.mercola.com…the-most-dangerous-aspect-of-vaccines.aspx http://articles.mercola.com…one-mercury-containing-vaccine.aspx http://www.nvic.org…vaccine-injury-claims-expected-to-increase-2016.aspx http://www.nvic.org/cmstemplates/nvic/pdf/downloads/adult-handout.pdf http://articles.mercola.com…vaccination-dangers.aspx http://www.nvic.org…Vaccinations–Know-the-risks-and-failures-.aspx About the Author: Michelle Goldstein is a mental health therapist who is passionate about holistic health, natural healing, nutrient-dense foods and the politics t...
Publication date: 15 February 2021Source: Journal of Hazardous Materials, Volume 404, Part BAuthor(s): Yanhua Liu, Yang Li, Shanshan Dong, Lu Han, Ruixin Guo, Yourong Fu, Shenghu Zhang, Jianqiu Chen
We describe the most highly recommended generic and disease-specific PRO tools in SCD and discuss the challenges of incorporating them in clinical practice. EXPERT OPINION: PRO measures are essential to incorporate into SCD clinical trials either as primary or secondary outcomes. The use of PRO measures in SCD facilitates a patient-centered approach, which is likely to lead to improved outcomes. Significant challenges remain in adapting PRO tools to routine clinical use and in developing countries. PMID: 33034214 [PubMed - as supplied by publisher]
Authors: Musio F Abstract INTRODUCTION: Anemia has and will continue to be a central theme in medicine particularly as clinicians are treating a burgeoning population of complex multi-organ system processes. As a result of multiple randomized controlled trials (RCTs), meta-analyses, and societal recommendations overly restrictive paradigms and under-administration of erythropoiesis stimulating agents (ESAs) have likely been followed by clinicians among all specialties. AREAS COVERED: A review of anemia in the context of chronic kidney disease, hematologic malignancies and cancer is presented with focus on the e...
Publication date: Available online 10 October 2020Source: Journal of Genetics and GenomicsAuthor(s): Chengqi Wang, Justin Gibbons, Swamy R. Adapa, Jenna Oberstaller, Xiangyun Liao, Min Zhang, John H. Adams, Rays H.Y. Jiang
Publication date: Available online 10 October 2020Source: Meta GeneAuthor(s): Mansour Zamanpoor, Hamid Ghaedi, Mir Davood Omrani
Publication date: January 2021Source: Urology Case Reports, Volume 34Author(s): Nina Al-Saadi, Safa Al-Musawi, Yousuf Khan, Daben Dawam
Currently in fellowship doing bread/butter procedures (MBB, epidurals, PNB, few SCS/PNS trials, etc.) and just interviewed at a private practice spot where they do a lot of procedures that I will have not done any training in prior to graduating (e.g. IT pump, SI fusion, Vertiflex, Kypho, MILD, Discectomy, lots of SCS/PNS trials etc) and significant amount of "OR pain procedures" at a very busy practice seeing 30-40 pts/day - how many of you are commonly performing these procedures and are... private practice concern
Authors: Matti B, Zargar-Shoshtari K Abstract Prostate cancer represents a significant health burden worldwide. The cancer incidence had substantially increased since the introduction of prostate specific antigen (PSA) in cancer screening. This had led to considerable debates among health professionals and epidemiologists, since PSA as a screening tool seemed to be far from perfect. In New Zealand, the controversy was quite prominent in the last three decades, with some advocating the benefits of screening, while others concerned regarding the risk of harms. With the absence of an organised screening programme and ...
CONCLUSION: The proposed PHARMAC criteria will give access to these important drugs to those people with T2DM who will likely benefit the most. PMID: 33032305 [PubMed - in process]
CONCLUSION: This study found that childhood cancer survivors in New Zealand had a high prevalence of developmental dental abnormalities and it identified potential risk factors related to their cancer treatment. Inequitable access to oral rehabilitation for this patient group argues for a mechanism for consistent improved access to publicly funded dental care across district health boards in New Zealand. PMID: 33032302 [PubMed - in process]
More News: Academies | ADHD | AIDS Vaccine | Anaphylactic Shock | Arthritis | Autoimmune Disease | Brain | Brain Cancers | Bursitis | Cancer | Cancer & Oncology | Cancer Vaccines | Cardiology | Child Development | Children | Chronic Pain | Dengue Fever | Diabetes | Diphtheria | Eating Disorders & Weight Management | Employment | Endocrinology | Epidemics | Epidemiology | Guillain-Barr Syndrome | Health | Health Management | Health Medicine & Bioethics Commentators | Heart | Heart Disease | Hepatitis | Hepatitis A | Hepatitis B | Hepatitis Vaccine | HIV AIDS | Influenza | Influenza Vaccine | Legislation | Malaria | Malaria Vaccine | Measles | Measles Vaccine | Men | Meningitis | Meningitis Vaccine | Neurology | Nutrition | Obesity | Pain | Pneomococcal Vaccine | Polio | Polio Vaccine | Politics | Rheumatology | Shingles | Shingles (Herpes Zoster) Vaccine | Smallpox | Smallpox Vaccine | Study | Tetanus | Tetanus Vaccine | Thrombocytopenia | Tuberculosis | Vaccines | Varicella-Zoster Virus Vaccine | Websites | West Nile Virus